Vanguard Capital Management’s Sutro Biopharma STRO Stock Holding History
Bought
Maintained
Sold
Other funds holding STRO
KCM
Vanguard Capital Management's STRO Position: Q3 2026 in Review
Vanguard Capital Management reduced its Sutro Biopharma (STRO) stake by 2.5% in Q3 2026, selling an estimated $382K and leaving 676,926 shares worth $10.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2704.
Vanguard Capital Management first reported a position in STRO in Q1 2026 and has held it in 3 quarters since. The position peaked at $23M in Q2 2026. 107 funds tracked by Wall St. Rank hold STRO as of Q3 2026.
- Vanguard Capital Management held 676,926 shares of Sutro Biopharma worth $10.9M as of Q3 2026.
- Vanguard Capital Management sold 17,293 Sutro Biopharma shares in Q3 2026, an estimated $382K.
- Sutro Biopharma made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2704 holding.
- Vanguard Capital Management first reported a position in Sutro Biopharma in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Sutro Biopharma position peaked at $23M in Q2 2026.
- 107 funds tracked by Wall St. Rank held Sutro Biopharma as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.